Trial Outcomes & Findings for The Darlington Retrospective Outpatient Study (NCT NCT01013883)
NCT ID: NCT01013883
Last Updated: 2014-03-14
Results Overview
Recruitment status
COMPLETED
Target enrollment
509 participants
Primary outcome timeframe
Patients would be followed up for average of 7 years
Results posted on
2014-03-14
Participant Flow
Patients referred to the one stop diagnostic heart failure clinic from Jan 2002 to Dec 2007, were followed up till Aug 2011.
Participant milestones
| Measure |
Systolic Dysfunction
patients having left ventricular systolic dysfunction on echocardiography
|
Distolic Heart Failure
patients with clinical heart failure and preserved LV systolic dysfunction
|
|---|---|---|
|
Overall Study
STARTED
|
270
|
243
|
|
Overall Study
COMPLETED
|
268
|
241
|
|
Overall Study
NOT COMPLETED
|
2
|
2
|
Reasons for withdrawal
| Measure |
Systolic Dysfunction
patients having left ventricular systolic dysfunction on echocardiography
|
Distolic Heart Failure
patients with clinical heart failure and preserved LV systolic dysfunction
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
2
|
2
|
Baseline Characteristics
The Darlington Retrospective Outpatient Study
Baseline characteristics by cohort
| Measure |
Systolic Dysfunction
n=268 Participants
patients having left ventricular systolic dysfunction on echocardiography
|
Distolic Heart Failure
n=241 Participants
patients with clinical heart failure and preserved LV systolic dysfunction
|
Total
n=509 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
49 Participants
n=93 Participants
|
21 Participants
n=4 Participants
|
70 Participants
n=27 Participants
|
|
Age, Categorical
>=65 years
|
219 Participants
n=93 Participants
|
220 Participants
n=4 Participants
|
439 Participants
n=27 Participants
|
|
Age, Continuous
|
74 years
STANDARD_DEVIATION 10 • n=93 Participants
|
78 years
STANDARD_DEVIATION 8 • n=4 Participants
|
76 years
STANDARD_DEVIATION 10 • n=27 Participants
|
|
Sex: Female, Male
Female
|
104 Participants
n=93 Participants
|
157 Participants
n=4 Participants
|
261 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
164 Participants
n=93 Participants
|
84 Participants
n=4 Participants
|
248 Participants
n=27 Participants
|
|
Region of Enrollment
United Kingdom
|
268 participants
n=93 Participants
|
241 participants
n=4 Participants
|
509 participants
n=27 Participants
|
PRIMARY outcome
Timeframe: Patients would be followed up for average of 7 yearsOutcome measures
| Measure |
Systolic Dysfunction
n=268 Participants
patients having left ventricular systolic dysfunction on echocardiography
|
Distolic Heart Failure
n=241 Participants
patients with clinical heart failure and preserved LV systolic dysfunction
|
|---|---|---|
|
All Cause Mortality
|
163 participants
|
118 participants
|
SECONDARY outcome
Timeframe: Patients would be followed up for average of 7yearsOutcome measures
| Measure |
Systolic Dysfunction
n=268 Participants
patients having left ventricular systolic dysfunction on echocardiography
|
Distolic Heart Failure
n=241 Participants
patients with clinical heart failure and preserved LV systolic dysfunction
|
|---|---|---|
|
Cardiovascular Mortality
|
113 participants
Interval 0.315 to 0.61
|
51 participants
|
SECONDARY outcome
Timeframe: During the follow up period of 7 yearsNumber of patients admitted to the hospital will be recorded
Outcome measures
| Measure |
Systolic Dysfunction
n=268 Participants
patients having left ventricular systolic dysfunction on echocardiography
|
Distolic Heart Failure
n=241 Participants
patients with clinical heart failure and preserved LV systolic dysfunction
|
|---|---|---|
|
Admission to Hospital for Any Cause
|
189 participants
Interval 0.292 to 0.519
|
158 participants
Interval 0.292 to 0.519
|
Adverse Events
Systolic Dysfunction
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Distolic Heart Failure
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place